[Different influence of Her-2 expression on the prognosis in node-positive and node-negative breast cancer].
Wang
Yan
Y
Breast Center, Peking University School of Oncology, Beijing Cancer Hospital & Institute, Beijing 100142, China.
Yao
Lu
L
Liu
Yi-qang
YQ
Xu
Ye
Y
Ou
Yang-tao
YT
Li
Jin-feng
JF
Wang
Tian-feng
TF
Fan
Zhao-qing
ZQ
Fan
Tie
T
Lin
Ben-yao
BY
Xie
Yun-tao
YT
D000328:Adult; D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D001943:Breast Neoplasms / Q000378:metabolism* / Q000473:pathology*; D018572:Disease-Free Survival; D005260:Female; D005500:Follow-Up Studies; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D008198:Lymph Nodes / Q000473:pathology*; D008207:Lymphatic Metastasis; D008875:Middle Aged; D009367:Neoplasm Staging; D016016:Proportional Hazards Models; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000378:metabolism*; D011980:Receptors, Progesterone / Q000378:metabolism; D015996:Survival Rate
D018719:Erb-b2 Receptor Tyrosine Kinases; D011980:Receptors, Progesterone; C508053:ERBB2 protein, human